Endometrial Cancer is more common than you think:
- Endometrial cancer is the most common female genital tract malignancy.
- It is the 4th most common cancer (behind lung, breast and colon) in women.
- More than 42,000 cases are diagnosed every year.
- Over seven thousand women die from it annually (twice as many as cervical cancer!)
The American Cancer Society states that of the 50 million Pap smears done annually, 5-7% report abnormal results. That equals 2.5 – 3.5 million women who are affected by abnormal Pap smears alone and have to undergo endometrial biopsies or colposcopies as a result.
It is calculated that 30-40% of all Ob/Gyn visits involve abnormal uterine bleeding. In these cases, tests for Chlamydia and Gonorrhea along with endometrial biopsies are often ordered, often at great discomfort for the patient. Why go through this when there is a better way?
Using a series of soft bristle brushes, Gynecor’s™ new TruTest™ for Total Uterine Testing is a quick and comfortable way to collect an endometrial biopsy right in the physician’s office.
Gynecor’s™ new Resolve™ Comprehensive Colposcopy takes a more complete look than standard colposcopy results and reports on HPV at the same time.
Both tests provide the physician with data that is useful when weighing treatment options, and address abnormal bleeding, cervical health, endometrial cancer, ovulation trends, HPV, Chlamydia and gonorrhea … all at once.
Ask about Gynecor’s™ new TruTest™ endometrial biopsy or Resolve™ Comprehensive Colposcopy today! |